Breast surgery and sentinel node biopsy. Our experience.

G Chir

Dipartimento Chirurgia Testa Collo e Tessuli Molli, Centro di Riferimento Regionale, Azienda Ospedaliera Santa Maria, Terni.

Published: March 2006

Massive campaigns of screening of breast pathologies improved early diagnosis of breast cancers. Most of these cancers are small-sized (T1) and seldom show intraoperative nodal involvement. Sentinel node biopsy is the elective choice in the above mentioned cases because, if negative, it avoids axillary dissection. International literature reports rates of false negative sentinel node biopsy ranging among 4.5 and 12%; results in our experience account for almost 6%. As a consequence, there is the definite risk of potentially positive axilla that will not be dissected with subsequent risk of axillary recurrence within 24 months. The reason of that could be related to the fact that in Referral Centers this technique is performed in strictly selected patients, so as to gain a diagnostic accuracy of 98%. The rate of axillary recurrences does not justify the routine axillary dissection, since this is just a staging, not a therapeutic procedure. In case of doubt, it can be recommended a close and careful follow-up of the axilla.

Download full-text PDF

Source

Publication Analysis

Top Keywords

sentinel node
12
node biopsy
12
axillary dissection
8
breast surgery
4
surgery sentinel
4
biopsy experience
4
experience massive
4
massive campaigns
4
campaigns screening
4
screening breast
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!